AMEX:RVP

Stock Analysis Report

Retractable Technologies

Executive Summary

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States and internationally.

Snowflake

Fundamentals

Flawless balance sheet and overvalued.

Risks

  • Retractable Technologies has significant price volatility in the past 3 months.
  • Retractable Technologies is not covered by any analysts.

Similar Companies

Share Price & News

How has Retractable Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

12.5%

RVP

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

27.4%

RVP

9.5%

US Medical Equipment

1.1%

US Market

RVP outperformed the Medical Equipment industry which returned 9.5% over the past year.

RVP outperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

RVPIndustryMarket
7 Day12.5%0.7%-0.2%
30 Day20.8%0.1%2.5%
90 Day36.9%2.5%1.6%
1 Year27.4%27.4%10.4%9.5%3.4%1.1%
3 Year-63.3%-63.3%69.3%64.1%45.2%35.8%
5 Year-66.6%-66.6%138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is Retractable Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Retractable Technologies undervalued based on future cash flows and its price relative to the stock market?

1.29x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Retractable Technologies to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Retractable Technologies to establish if it is available at substantial discount.


Price Based on Earnings

Retractable Technologies is loss making, we can't compare its value to the US Medical Equipment industry average.

Retractable Technologies is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Retractable Technologies, we can't assess if its growth is good value.


Price Based on Value of Assets

Retractable Technologies is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Retractable Technologies expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Retractable Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Retractable Technologies performed over the past 5 years?

-11.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Retractable Technologies does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Retractable Technologies's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Retractable Technologies's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

Retractable Technologies has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

It is difficult to establish if Retractable Technologies has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Retractable Technologies improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Retractable Technologies's financial position?


Financial Position Analysis

Retractable Technologies is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Retractable Technologies's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Retractable Technologies's level of debt (11%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (14.4% vs 11% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 8.9x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Retractable Technologies has sufficient cash runway for more than 3 years based on current free cash flow.

Retractable Technologies has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of -33.3% each year.


Next Steps

Dividend

What is Retractable Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Retractable Technologies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Retractable Technologies's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Retractable Technologies has not reported any payouts.

Unable to verify if Retractable Technologies's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Retractable Technologies has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Retractable Technologies's salary, the management and board of directors tenure and is there insider trading?

21.7yrs

Average management tenure


CEO

Thomas Shaw (68yo)

25.7yrs

Tenure

US$495,747

Compensation

Mr. Thomas J. Shaw is Founder of Retractable Technologies, Inc. and serves as its Chief Executive Officer and President. Mr. Shaw has over 25 years of experience in industrial product design and has develo ...


CEO Compensation Analysis

Thomas's remuneration is about average for companies of similar size in United States of America.

Thomas's compensation has increased whilst company is loss making.


Management Age and Tenure

21.7yrs

Average Tenure

59yo

Average Age

The average tenure for the Retractable Technologies management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

9.5yrs

Average Tenure

54.5yo

Average Age

The tenure for the Retractable Technologies board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Kathryn Duesman (56yo)

    Executive Director of Global Health

    • Tenure: 0yrs
    • Compensation: US$224.88k
  • Lawrence Salerno (59yo)

    Director of Operations

    • Tenure: 21.7yrs
  • Russell Kuhlman (65yo)

    Vice President of Sales Development

    • Tenure: 0yrs
    • Compensation: US$179.62k
  • Michele Larios (53yo)

    VP, General Counsel & Secretary

    • Tenure: 0yrs
    • Compensation: US$391.70k
  • Thomas Shaw (68yo)

    Founder

    • Tenure: 25.7yrs
    • Compensation: US$495.75k
  • John Fort (50yo)

    Director

    • Tenure: 0.4yrs
  • Patti King (61yo)

    Director of National Accounts

    • Tenure: 0yrs
    • Compensation: US$140.88k

Board Members

  • Thomas Shaw (68yo)

    Founder

    • Tenure: 25.7yrs
    • Compensation: US$495.75k
  • John Fort (50yo)

    Director

    • Tenure: 0.4yrs
  • Marco Laterza (71yo)

    Independent Director

    • Tenure: 14.5yrs
    • Compensation: US$2.50k
  • Amy Mack (51yo)

    Independent Director

    • Tenure: 11.8yrs
    • Compensation: US$2.50k
  • Walter Bigby (54yo)

    Independent Director

    • Tenure: 7.2yrs
    • Compensation: US$2.50k
  • Darren Findley (55yo)

    Independent Director

    • Tenure: 2yrs
    • Compensation: US$2.50k

Company Information

Retractable Technologies, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Retractable Technologies, Inc.
  • Ticker: RVP
  • Exchange: AMEX
  • Founded: 1994
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$32.348m
  • Shares outstanding: 32.67m
  • Website: https://www.retractable.com

Number of Employees


Location

  • Retractable Technologies, Inc.
  • 511 Lobo Lane
  • Little Elm
  • Texas
  • 75068
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RVPAMEX (NYSE MKT LLC)YesCommon StockUSUSDMay 2001

Biography

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other medical products for the healthcare industry in the United States and internationally. It principally o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 23:41
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.